Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

Priya Rathi; Kalpita Shringarpure; Bhaskaran Unnikrishnan; Vineet Kumar Chadha; Vishak Acharya; Abirami Nair; Karuna D. Sagili; Suresh Shastri

doi:10.3201/eid2605.181992

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

Priya Rathi, Kalpita Shringarpure, Bhaskaran Unnikrishnan, Vineet Kumar Chadha, Vishak Acharya, Abirami Nair, Karuna D. Sagili, Suresh Shastri

Research output: Contribution to journal › Article

Abstract

In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

Original language	English
Pages (from-to)	989-992
Number of pages	4
Journal	Emerging Infectious Diseases
Volume	26
Issue number	5
DOIs	https://doi.org/10.3201/eid2605.181992
Publication status	Published - 01-05-2020

All Science Journal Classification (ASJC) codes

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid2605.181992

Fingerprint Dive into the research topics of 'Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017'. Together they form a unique fingerprint.

Cite this

Rathi, P., Shringarpure, K., Unnikrishnan, B., Chadha, V. K., Acharya, V., Nair, A., Sagili, K. D., & Shastri, S. (2020). Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017. Emerging Infectious Diseases, 26(5), 989-992. https://doi.org/10.3201/eid2605.181992

@article{45bd8057d9394e259122e0660d38d9f0,

title = "Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017",

abstract = "In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.",

author = "Priya Rathi and Kalpita Shringarpure and Bhaskaran Unnikrishnan and Chadha, {Vineet Kumar} and Vishak Acharya and Abirami Nair and Sagili, {Karuna D.} and Suresh Shastri",

year = "2020",

month = may,

day = "1",

doi = "10.3201/eid2605.181992",

language = "English",

volume = "26",

pages = "989--992",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "5",

}

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017. / Rathi, Priya; Shringarpure, Kalpita; Unnikrishnan, Bhaskaran; Chadha, Vineet Kumar; Acharya, Vishak; Nair, Abirami; Sagili, Karuna D.; Shastri, Suresh.

In: Emerging Infectious Diseases, Vol. 26, No. 5, 01.05.2020, p. 989-992.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

AU - Rathi, Priya

AU - Shringarpure, Kalpita

AU - Unnikrishnan, Bhaskaran

AU - Chadha, Vineet Kumar

AU - Acharya, Vishak

AU - Nair, Abirami

AU - Sagili, Karuna D.

AU - Shastri, Suresh

PY - 2020/5/1

Y1 - 2020/5/1

N2 - In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

AB - In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

UR - http://www.scopus.com/inward/record.url?scp=85083914578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083914578&partnerID=8YFLogxK

U2 - 10.3201/eid2605.181992

DO - 10.3201/eid2605.181992

M3 - Article

C2 - 32310069

AN - SCOPUS:85083914578

VL - 26

SP - 989

EP - 992

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 5

ER -